Condition (MeSH)
Cat-Scratch Disease
ClinicalTrials.gov lists 2 trials for Cat-Scratch Disease or a narrower condition beneath it. Tel-Aviv Sourasky Medical Center has the most among industry and government lead sponsors, with 1.
Search trials, drugs, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Trials per phase
2 of the 2 trials are tagged with Cat-Scratch Disease itself; the rest are tagged with a narrower condition beneath it.
When did Cat-Scratch Disease trials start? (2)
Shown in this order: most recent first, 1990 onwards. 2026 is partial: trials registered with a 2026 start date so far, not a full year.
| Year | Trials started |
|---|---|
| 2017 | 1 |
| 2011 | 1 |
No forecast is made for this condition: it averages 0.0 trial starts a year over the five years to September, under the 5 a year the method needs.
Recruitment duration, a model prediction: none of the 2 trials evaluated at the 2026-10-09 snapshot is predicted and still running. Source: ClinicalTrials.gov / AACT (CTTI), public domain.
What phase are Cat-Scratch Disease trials in? (2)
Shown in this order: phase order.
Show the trials by phase as a table
| Phase | Trials |
|---|---|
| Phase 3 | 1 |
| Phase 4 | 1 |
How many Cat-Scratch Disease trials are recruiting? (2)
Shown in this order: the order a trial moves through, from not yet recruiting to unknown.
| Status | Trials |
|---|---|
| Completed | 1 |
| Unknown status | 1 |
Status as registered on ClinicalTrials.gov. Each trial is counted once.
Which lead sponsors run the most Cat-Scratch Disease trials? (1)
Shown in this order: most trials first. Lead sponsors the registry classes as industry, NIH, US federal, other government or network. A hospital or university the registry files as government can appear here. Sponsors it classes as academic or other are shown on the full page, because that class cannot separate an institution from a named investigator.
| Sponsor | Trials |
|---|---|
| Tel-Aviv Sourasky Medical Center | 1 |
Which publications cover Cat-Scratch Disease? (2)
Shown in this order: major-topic papers first, then newest, then most linked to trials.
| Publication | Journal | Year | Major topic |
|---|---|---|---|
| Pediatric neck masses: how clinical and radiological features can drive diagnosis. | European journal of pediatrics | 2019 | Yes |
| Bartonella: emerging pathogen or emerging awareness? | International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases | 2009 | No |
Prevalence (3)
Shown in this order: jurisdiction, then disease name. Orphanet observation for the mapped ORPHA concept; the mapping relation column says whether that concept is exactly this condition or broader or narrower.
| Orphanet disease | Type | Class | Geography | Jurisdiction | Mapping relation |
|---|---|---|---|---|---|
| Cat-scratch disease | Point prevalence | 1-9 / 100 000 | Europe | Not stated | Exact |
| Cat-scratch disease | Point prevalence | 1-9 / 100 000 | Europe | Not stated | Exact |
| Cat-scratch disease | Point prevalence | 1-9 / 100 000 | Europe | Not stated | Unspecified |
Rare-disease identity (2)
Shown in this order: exact, broader, narrower, other.
| Orphanet disease | ORPHA code | Relation | Source |
|---|---|---|---|
| Cat-scratch disease | 50839 | Exact | Orphadata Science knowledge files, Product 1 |
| Cat-scratch disease | 50839 | Exact | Orphanet Rare Disease Ontology (ORDO) |
Not on this page
Not measured: delivery record.
Checked, with nothing recorded for this condition: serious adverse events in this condition's trials and sub-conditions in mesh.
Not computed for conditions with fewer than 10 trials: drugs tested.